Cargando…
Atovaquone exerts its anticancer effect by inhibiting Na(+)/K(+)-ATPase ion transport in canine cancer cells
BACKGROUND AND AIM: New anticancer drugs are being developed to avoid the toxicity and chemoresistance of the currently available drugs. The Food and Drug Administration-approved anti-malarial drug atovaquone is known to act as a selective oxidative phosphorylation inhibitor in the mitochondria by c...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Veterinary World
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10421541/ https://www.ncbi.nlm.nih.gov/pubmed/37577204 http://dx.doi.org/10.14202/vetworld.2023.1185-1192 |